Background: Obesity is a growing global health concern and poses significant challenges in rectal cancer surgery. Excess visceral fat can obscure surgical landmarks, complicate dissection, and increase the risk of intraoperative adverse events (iAEs). Despite these recognized difficulties, there is limited objective data quantifying the impact of obesity on intraoperative complications. This study utilizes the CLASSIntra classification system to assess the incidence and severity of iAEs in patients with obesity (BMI ≥ 30 kg/m 2 ) undergoing rectal cancer resection. Methods: This retrospective cohort study reviewed patients undergoing rectal cancer resection between January 2014 and December 2023. Patients were stratified into groups by BMI (obese (BMI≥ 30 kg/m 2 ) versus non‐obese (BMI < 30 kg/m 2 )). The primary outcome was the incidence and severity of iAEs, graded using the CLASSIntra system. Secondary outcomes included conversion to open surgery, postoperative complications, ICU admissions, and overall length of stay. Results: There were 350 patients included (112 obese, 238 non‐obese). There were significantly more iAEs in the obese group (40% vs. 26%, p = 0.010). Obesity was an independent predictor of intraoperative complications (OR 1.92, p = 0.010). Conversion to open surgery (27% vs. 40%, OR 2.30, p = 0.0100) and ICU readmission (50% vs. 31%, OR 2.35, p = 0.003) were significantly more common in patients with obesity. There were no significant differences in postoperative complication rates and hospital length of stay between groups. Conclusion: Obesity leads to a higher risk of intraoperative complications in rectal cancer surgery, increased conversion rates, and greater ICU resource utilisation. These findings highlight the technical challenges of rectal surgery in obese patients and emphasize the need for tailored preoperative planning, prehabilitation, and intraoperative strategies. Despite these intraoperative difficulties, structured postoperative care appears to mitigate differences in postoperative outcomes. Further research should explore preoperative interventions, such as weight optimization programs, to improve surgical outcomes in this high‐risk population.
Background: Anastomotic leak (AL) is a serious complication following colon cancer resection, but its long‐term impact on survival and recurrence remains uncertain. Objective: To evaluate the association between AL and postoperative outcomes, including overall survival (OS), replase‐free survival (RFS), and cancer‐specific survival (CSS), and to identify factors associated with increased risk of leak. Methods: This retrospective cohort study included 2217 patients with histologically confirmed Stage I–III colon adenocarcinoma who underwent curative‐intent resection with primary anastomosis across three tertiary centres (2009–2025). Patients with benign pathology, carcinoma in situ (Stage 0), metastatic disease, or missing follow‐up data were excluded. ALs were defined as clinically and/or radiologically confirmed disruptions occurring within 30 days postoperatively. No leaks were observed beyond this period. Outcomes were compared using Kaplan–Meier estimates and Cox regression models. Results: ALs, either clinical or radiological, occurred in 2.0% of patients ( n = 44). Leaks were associated with significantly increased 30‐day mortality (6.8% vs. 0.4%, p < 0.001), reoperation (86.4% vs. 3.4%, p < 0.001), and hospital stay (median 21 vs. 7 days, p < 0.001). In multivariable analysis, AL independently predicted 30‐day mortality (AOR 13.6, 95% CI 9.9–18.6) and return to theatre (AOR 396.2, 95% CI 218.8–717.4). AL was associated with worse OS and DFS, but not CSS ( p = 0.66). Conclusions: AL is an independent predictor of postoperative morbidity and long‐term nononcologic mortality in colon cancer patients. While OS and DFS were significantly reduced, CSS remained unaffected, a unique finding that challenges assumptions about leak‐related oncologic progression. These results suggest that excess mortality stems from systemic complications and care disruption rather than cancer recurrence. Preventive strategies and early leak detection in high‐risk patients are essential to improving outcomes.